Clinical Trial Update: Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/3 study evaluating regorafenib with low-dose chemotherapies and aspirin, followed by standard chemotherapies, for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aspirin (Aspirin)
• Regorafenib (regorafenib)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Metastatic Colorectal Cancer | Phase 2, Phase 3 | Status: RECRUITING